Nephros, Inc. (NEPH)
NASDAQ: NEPH · Real-Time Price · USD
4.060
-0.210 (-4.92%)
At close: Sep 18, 2025, 4:00 PM EDT
4.060
0.00 (0.00%)
After-hours: Sep 18, 2025, 4:00 PM EDT
Nephros Market Cap
Nephros has a market cap or net worth of $42.51 million as of September 18, 2025. Its market cap has increased by 120.25% in one year.
Market Cap
42.51M
Enterprise Value
40.27M
1-Year Change
120.25%
Ranking
Category
Stock Price
$4.06
Market Cap Chart
Since August 15, 2019, Nephros's market cap has decreased from $54.10M to $42.51M, a decrease of -21.43%. That is a compound annual growth rate of -3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 45.30M | 192.26% |
| Dec 31, 2024 | 15.50M | -57.30% |
| Dec 29, 2023 | 36.30M | 205.04% |
| Dec 30, 2022 | 11.90M | -80.30% |
| Dec 31, 2021 | 60.40M | -28.61% |
| Dec 31, 2020 | 84.60M | 6.82% |
| Dec 31, 2019 | 79.20M | 46.40% |
| Aug 15, 2019 | 54.10M | - |
View and export this data all the way back to 2019. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 686.51B |
| Johnson & Johnson | 424.98B |
| AbbVie | 382.04B |
| UnitedHealth Group | 307.73B |
| Novo Nordisk | 253.09B |
| AstraZeneca | 240.11B |
| Novartis AG | 237.94B |
| Abbott Laboratories | 231.06B |